Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues...
Yael Mardor, PhD from the Chaim Sheba Medical Center in Tel Aviv, Israel, discusses how delayed contrast extravasation magnetic resonance imaging (MRI) can be used to depict tumor and non-tumoral tissues in primary and secondary or metastatic brain tumors. She begins by explaining the method for acquiring the images for Contrast Clearance Assessment and how the resulting images can be analyzed to support the distinction between tumor progression and treatment effects. She then provides case examples to demonstrate the methodology and concludes with their findings.
About the speaker
Mardor Yael, PhD
The Chaim Medical Center, Israel
The Means for Radiosurgery Quality Management: Novalis Certified
Trajectory Based Treatment Planning and Delivery for Cranial Radiosurgery
Reporting Clinical Outcomes via the NeuroPoint Alliance National...
Advanced MR and PET Imaging: Is it Really Useful in Brain Tumor Radiosurgery?
Image-guided Patient Monitoring Innovations
Contrast Clearance Analysis for Differentiating Tumor From Treatment Effects
Value of Fibertracking for Target Definition and Pre-planning Requirements for Safe Thalamatomies
Clinical Advantages of Elements with ExacTrac
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.WATCH Video
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.Watch video No Thanks
Already Novalis Circle Member?Member Login